论文信息 - Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–Human Epidermal Growth Factor Receptor 2 Therapy - 字舞流文

Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–Human Epidermal Growth Factor Receptor 2 Therapy

A. Schneeweiss | R. Gelber | M. Buyse | M. Piccart | G. Tang | C. Geyer | E. Saad | S. Loibl | M. Untch | H. Bonnefoi | D. Cameron | V. Nekljudova | C. Jackisch | L. Gianni | P. Squifflet | E. de Azambuja | P. Valagussa | C. Poncet | P. Conte | P. Cortazar | J. Cortés | V. Guarneri | G. Ismael | D. Heinzmann | N. Wolmark | C. Neate | Priya Rastogi | C. Denkert | M. V. van Mackelenbergh